ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Regulatory AI Capability Lead at Gilead Sciences - ApplyBlast

Regulatory AI Capability Lead

Gilead Sciences

1 month ago

3.5 on Glassdoor

Mississauga, Ontario, Canada

Onsite

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Gilead Sciences is seeking a Regulatory AI Capability Lead to advance operational effectiveness and digital enablement across CMC Regulatory Affairs. This role involves leading business process design, optimization, and digital automation initiatives while partnering with cross-functional teams to implement sustainable solutions. The position requires a strong understanding of regulatory operations combined with expertise in process improvement, data analytics, and change management.

Responsibilities

Lead business process mapping, analysis, design, and optimization across CMC Regulatory Affairs
Translate regulatory operational needs into digital and automation solutions with IT partners
Drive cross-functional initiatives and organizational change to implement new processes and tools

Skills

About Gilead Sciences

gilead.com

Headquarters

Foster City, California, United States

Company Size

10001+ employees

Founded

1987

View Profile

Gilead Sciences is a biopharmaceutical company dedicated to transforming patient care by advancing therapeutics in areas like HIV, liver disease, cancer, and inflammation. With a strong commitment to innovation, Gilead leads in the research and development of new medicines, aiming to make the world a healthier place. Their portfolio includes breakthrough therapies and ongoing advancements across multiple therapeutic areas, supported by a robust pipeline of clinical trials. Gilead is recognized for its contributions to public health and its efforts to improve access to vital medications.